Full Breakdown
Hong Kong's Blueprint for Chinese Medicine Development
12/18/2025, 10:24:41 PM
Introduction of the Chinese Medicine Development Blueprint
On December 18, 2023, Hong Kong's health authorities unveiled the "Chinese Medicine Development Blueprint," aimed at promoting the global reach of Chinese medicine. This initiative seeks to leverage Hong Kong's strengths in healthcare quality and international reputation to establish international standards for medicinal products and enhance professional competence. Secretary for Health Lo Chung-mau emphasized the importance of this blueprint in aligning with Beijing's national strategy, which recognizes Chinese medicine as a vital component of the modern healthcare system.
Objectives and Key Areas of Focus
The blueprint outlines five key areas and eight goals, including amending the Chinese Medicine Ordinance to eliminate regulatory "grey areas" that previously allowed products to bypass safety checks. The initiative aims to integrate Chinese medicine as an equal partner alongside Western medicine, fostering a comprehensive healthcare system that benefits both local and international communities.
Support from the Chinese Medicine Council of Hong Kong
The Chinese Medicine Council of Hong Kong (CMCHK) expressed strong support for the blueprint, viewing it as a significant milestone in the development of Chinese medicine in the region. CMCHK Chairman Mrs. Jeanie Hu stated that the blueprint provides a clear direction for the long-term growth of Chinese medicine, emphasizing the need for collaboration among the government, industry, and stakeholders to ensure professional standards and public health safety.
Role of the Hospital Authority
The Hospital Authority (HA) welcomed the blueprint, recognizing Chinese medicine as an integral part of Hong Kong's cultural heritage. The HA plans to align its initiatives with the government's policy direction, further enhancing the role of Chinese medicine within the healthcare system. Over the past two decades, the HA has established Chinese Medicine Clinics cum Training and Research Centres (CMCTRs) across 18 districts and launched various training programs to improve the clinical competency of local practitioners.
Criticism and Opposition
While the blueprint has garnered support from various stakeholders, some critics express concerns regarding the potential commercialization of Chinese medicine and the adequacy of regulatory measures to ensure product safety. These dissenting viewpoints highlight the need for ongoing dialogue and scrutiny as the blueprint is implemented.
Official Statements & Responses
The HA reiterated its commitment to promoting Chinese medicine, stating, "The blueprint sets out a comprehensive roadmap for the future development of CM in Hong Kong." This sentiment reflects a broader consensus among health authorities regarding the importance of integrating Chinese medicine into the healthcare framework.
What's Next
Moving forward, the HA will continue to collaborate with CMCTRs to enhance the integrated Chinese-Western medicine service network, aiming to provide quality healthcare services to a wider population. The successful implementation of the blueprint will be closely monitored to assess its impact on both local healthcare and the global positioning of Chinese medicine.
Verbatim Quotes
- “Building upon a 5,000-year heritage, Chinese medicine has a substantial discourse power in the field of traditional medicine, and it can be used to help people in other countries,” — Lo Chung-mau, Secretary for Health
- “The Chairman of the CMCHK, Mrs Jeanie Hu, said, "The release of the Blueprint marks a new milestone in the development of Chinese medicine in Hong Kong.” — Mrs. Jeanie Hu, Chairman of CMCHK
- “The blueprint sets out a comprehensive roadmap for the future development of CM in Hong Kong, which will further enhance the role and contribution of CM in Hong Kong's healthcare system.” — Hospital Authority Statement
